Burning Rock Biotech
BNR
17 hedge funds and large institutions have $14.7M invested in Burning Rock Biotech in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
6% more funds holding
Funds holding: 16 → 17 (+1)
0.77% more ownership
Funds ownership: 18.93% → 19.7% (+0.77%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
46% less capital invested
Capital invested by funds: $27.4M → $14.7M (-$12.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$401K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$248K |
| 3 |
Renaissance Technologies
New York
|
+$247K |
| 4 |
AIP
Almanack Investment Partners
Wayne,
Pennsylvania
|
+$229K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$193K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CRCM LP
San Francisco,
California
|
-$993K |
| 2 |
NAMA
Nikko Asset Management Americas
New York
|
-$5.85K |
| 3 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$5.85K |
| 4 |
JP Morgan Chase
New York
|
-$297 |
| 5 |
Citigroup
New York
|
-$16 |
BNR Hedge Fund Activity: Q2 2026 in Review
17 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q2 2026, worth a combined $14.7M — down 46% from $27.4M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BNR positions and 2 closed out — a net gain of 1 holder — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $401K. The largest seller was CRCM LP, cutting an estimated $993K.
- 17 institutional investors held Burning Rock Biotech (BNR) as of Q2 2026, up from 16 in Q1 2026.
- Funds reported $14.7M of Burning Rock Biotech stock for Q2 2026, down 46% quarter-over-quarter.
- 3 funds opened new Burning Rock Biotech positions in Q2 2026 and 2 closed out, a net change of +1 holder.
- The largest Burning Rock Biotech buyer in Q2 2026 was Morgan Stanley, an estimated $401K added.
- The largest Burning Rock Biotech seller in Q2 2026 was CRCM LP, an estimated $993K sold.
Based on aggregated 13F filings for Q2 2026.